Athersys Investigational Site 121 — Chicago, Illinois

Athersys Investigational Site 121 is a clinical research site located in Chicago, Illinois, United States 60201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Athersys Investigational Site 121 has participated in 1 clinical trials.

Therapeutic areas: Ischemic Stroke.

Sponsors: Healios K.K..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Athersys Investigational Site 121?

Athersys Investigational Site 121 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Athersys Investigational Site 121 conducted?

Athersys Investigational Site 121 has 1 clinical trials on record. Their work covers Ischemic Stroke.

Is Athersys Investigational Site 121 accredited by Crixeo Health?

Athersys Investigational Site 121 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Athersys Investigational Site 121?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.